GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Institutional Ownership

OSE Immunotherapeutics (XPAR:OSE) Institutional Ownership : 2.48% (As of May. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OSE Immunotherapeutics's institutional ownership is 2.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OSE Immunotherapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OSE Immunotherapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.

OSE Immunotherapeutics Institutional Ownership Historical Data

The historical data trend for OSE Immunotherapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Institutional Ownership Chart

OSE Immunotherapeutics Historical Data

The historical data trend for OSE Immunotherapeutics can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 1.32 1.33 1.30 1.64 2.21 2.21 2.50 2.50 2.48 2.48

OSE Immunotherapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Institutional Ownership
Comparable Companies
XPAR:ADOC XPAR:MAAT XPAR:ALSEN XPAR:ALVAL XPAR:ALCLS XPAR:ALACT XPAR:TNG XPAR:ABNX XPAR:GNFT XPAR:ALGEN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
6OP:Germany
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
Website
http://www.ose-immuno.com
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines